Ryzodeg

(degludec/insulin aspart) Novo Nordisk

Composition:

• Available in 300 units/ 3 mL in solution for injection in a pre-filled pen containing basal insulin degludec and the rapid-acting prandial insulin aspart in the ratio 70/30

Indication:

• Indicated for the treatment of diabetes mellitus in adults, adolescents and children from the age of 2 years

Drug information updated in ‘The Pace’, including formulation, indication, administration and/or presentation being registered or available in Hong Kong within one year prior to the published date is regarded as new.

The information in The Pace is provided as a courtesy service to our readers and is intended for medical professional reference only. Please peruse the latest local prescription information prior to prescription.